Director Carolyn R. Bertozzi filed a Form 4 with the SEC on November 17, 2026, disclosing an acquisition of Eli Lilly common stock on November 16, 2026.

Key Highlights

  • Reporting person: Carolyn R. Bertozzi, identified as a Director of Eli Lilly & Co (NYSE:LLY).
  • Transaction: Acquisition (code A) of 177.7405 shares of common stock on November 16, 2026.
  • Price per share: $1,431.67, as reported in the filing.
  • Post-transaction ownership: Bertozzi directly holds 2,177.7405 shares of common stock following the transaction.
  • Signature: The form was signed by Jonathan Groff on behalf of Carolyn R. Bertozzi pursuant to an attached authorization.

Bertozzi's November 2026 Common Stock Acquisition at Eli Lilly

According to the filing, Director Carolyn R. Bertozzi acquired 177.7405 shares of Eli Lilly & Co common stock on November 16, 2026, at a price of $1,431.67 per share. The transaction is recorded as an acquisition (code A) in Table I of the Form 4, covering non-derivative securities. Ownership is reported as direct.

Following this transaction, the filing states that Bertozzi's total direct beneficial ownership of Eli Lilly common stock stands at 2,177.7405 shares. No derivative securities transactions were reported in Table II of the filing. The Form 4 was filed as an individual report by one reporting person, with Bertozzi's address listed as the Lilly Corporate Center in Indianapolis, Indiana.

The filing was signed on November 17, 2026, by Jonathan Groff for Carolyn R. Bertozzi pursuant to an authorization described as attached to the form. No amendment date is indicated, suggesting this is an original filing. The date of earliest transaction is listed as November 16, 2026.

What Was Disclosed

The filing disclosed a single acquisition of 177.7405 shares of Eli Lilly & Co common stock by Director Carolyn R. Bertozzi at $1,431.67 per share on November 16, 2026, bringing her total direct holdings to 2,177.7405 shares.